Cempra Pharmaceuticals.

PositionTRIANGLE

MORRISVILLE -- Cempra Pharmaceuticals, a startup that focuses on anti-infection drugs, added an investor to its first round of venture capital, pushing its take from $14 million to $22 million. New York-based Aisling Capital joined a group led by...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT